Logo image of DYNT

DYNATRONICS CORP (DYNT) Stock Fundamental Analysis

NASDAQ:DYNT - Nasdaq - US2681575005 - Common Stock - Currency: USD

0.244  +0.03 (+15.09%)

After market: 0.2174 -0.03 (-10.9%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DYNT. DYNT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of DYNT have multiple concerns. DYNT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DYNT has reported negative net income.
DYNT had a negative operating cash flow in the past year.
DYNT had negative earnings in 4 of the past 5 years.
Of the past 5 years DYNT 4 years had a positive operating cash flow.
DYNT Yearly Net Income VS EBIT VS OCF VS FCFDYNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

DYNT has a Return On Assets (-18.49%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -34.58%, DYNT is in line with its industry, outperforming 54.17% of the companies in the same industry.
Industry RankSector Rank
ROA -18.49%
ROE -34.58%
ROIC N/A
ROA(3y)-9.7%
ROA(5y)-8.98%
ROE(3y)-16.87%
ROE(5y)-16.12%
ROIC(3y)N/A
ROIC(5y)N/A
DYNT Yearly ROA, ROE, ROICDYNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

With a Gross Margin value of 21.39%, DYNT is not doing good in the industry: 79.17% of the companies in the same industry are doing better.
DYNT's Gross Margin has declined in the last couple of years.
DYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.02%
GM growth 5Y-4.64%
DYNT Yearly Profit, Operating, Gross MarginsDYNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

DYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DYNT has been increased compared to 1 year ago.
The number of shares outstanding for DYNT has been increased compared to 5 years ago.
The debt/assets ratio for DYNT is higher compared to a year ago.
DYNT Yearly Shares OutstandingDYNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
DYNT Yearly Total Debt VS Total AssetsDYNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -0.48, we must say that DYNT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DYNT (-0.48) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.26 indicates that DYNT is not too dependend on debt financing.
DYNT has a Debt to Equity ratio of 0.26. This is comparable to the rest of the industry: DYNT outperforms 46.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -0.48
ROIC/WACCN/A
WACC11.47%
DYNT Yearly LT Debt VS Equity VS FCFDYNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.40 indicates that DYNT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, DYNT is doing worse than 84.38% of the companies in the same industry.
A Quick Ratio of 0.68 indicates that DYNT may have some problems paying its short term obligations.
DYNT has a worse Quick ratio (0.68) than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.68
DYNT Yearly Current Assets VS Current LiabilitesDYNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

2

3. Growth

3.1 Past

DYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.53%, which is quite good.
Looking at the last year, DYNT shows a very negative growth in Revenue. The Revenue has decreased by -22.51% in the last year.
DYNT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.81% yearly.
EPS 1Y (TTM)10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.78%
Revenue 1Y (TTM)-22.51%
Revenue growth 3Y-8.73%
Revenue growth 5Y-8.81%
Sales Q2Q%-17.09%

3.2 Future

Based on estimates for the next years, DYNT will show a very strong growth in Earnings Per Share. The EPS will grow by 31.97% on average per year.
The Revenue is expected to decrease by -3.17% on average over the next years.
EPS Next Y35.73%
EPS Next 2Y31.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.58%
Revenue Next 2Y-3.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DYNT Yearly Revenue VS EstimatesDYNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
DYNT Yearly EPS VS EstimatesDYNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DYNT. In the last year negative earnings were reported.
Also next year DYNT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DYNT Price Earnings VS Forward Price EarningsDYNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYNT Per share dataDYNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as DYNT's earnings are expected to grow with 31.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.97%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DYNT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DYNATRONICS CORP

NASDAQ:DYNT (7/8/2024, 8:26:50 PM)

After market: 0.2174 -0.03 (-10.9%)

0.244

+0.03 (+15.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-09 2024-05-09/bmo
Earnings (Next)09-26 2024-09-26/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners90.62%
Ins Owner Change15.37%
Market Cap1.30M
Analysts82.86
Price Target4.08 (1572.13%)
Short Float %0.01%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.01%
Min EPS beat(2)-5.88%
Max EPS beat(2)35.9%
EPS beat(4)2
Avg EPS beat(4)-10.43%
Min EPS beat(4)-120.59%
Max EPS beat(4)48.85%
EPS beat(8)3
Avg EPS beat(8)-27.77%
EPS beat(12)5
Avg EPS beat(12)18.98%
EPS beat(16)7
Avg EPS beat(16)22.95%
Revenue beat(2)0
Avg Revenue beat(2)-1.93%
Min Revenue beat(2)-3.75%
Max Revenue beat(2)-0.11%
Revenue beat(4)2
Avg Revenue beat(4)0.49%
Min Revenue beat(4)-3.75%
Max Revenue beat(4)5.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.95%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)8
Avg Revenue beat(16)0.5%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB 0.28
EV/EBITDA N/A
EPS(TTM)-1.19
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS6.33
BVpS2.8
TBVpS0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.49%
ROE -34.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.39%
FCFM N/A
ROA(3y)-9.7%
ROA(5y)-8.98%
ROE(3y)-16.87%
ROE(5y)-16.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.02%
GM growth 5Y-4.64%
F-Score1
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.96%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.68
Altman-Z -0.48
F-Score1
WACC11.47%
ROIC/WACCN/A
Cap/Depr(3y)15.22%
Cap/Depr(5y)15.08%
Cap/Sales(3y)0.5%
Cap/Sales(5y)0.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.78%
EPS Next Y35.73%
EPS Next 2Y31.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.51%
Revenue growth 3Y-8.73%
Revenue growth 5Y-8.81%
Sales Q2Q%-17.09%
Revenue Next Year-14.58%
Revenue Next 2Y-3.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.15%
FCF growth 3Y-59.94%
FCF growth 5Y-19.12%
OCF growth 1Y40.91%
OCF growth 3Y-50.71%
OCF growth 5Y-13.41%